Archives

by in
Entry Author Date Location
Regeneron Eyes Potential Blockbuster With Asthma Drug 05/21/13 New York
Bellicum in Trials with Cancer Vaccine, Cell-Suicide Switches 05/16/13 Texas
Gradalis’s Fang Bares Its Teeth in Fighting Ovarian Cancer 05/15/13 Texas
Aveo Shares Plummet as FDA Advisory Panel Votes Down Cancer Drug 05/02/13 Boston
UW Spinoff Impel Neuropharma Passes Key Nose-to-Brain Clinical Trial 04/18/13 Seattle
Alkermes Stock Climbs on Positive Trial for Depression Drug 04/17/13 Boston
Re-thinking Clinical Trials for the World of Crowdsourcing 04/16/13 Boston
Acorda Stock Climbs on Post-Stroke Study 04/15/13 New York
With Kythera as Model, Lithera Tests Drug to Shrink ‘Love Handles’ 03/12/13 San Diego
Catabasis Passes First Trials With Anti-Inflammatory Drug 02/11/13 Boston
East Coast Life Sciences Roundup: Sarepta, Vertex, Celsion, More 02/01/13 Boston
Celsion Liver Cancer Trial Fails to Meet Goals, Stock Plunges 01/31/13 New York
Keryx Finally Succeeds With a Clinical Trial, for Kidney Disease Drug 01/28/13 New York
East Coast Life Sciences Roundup: Aveo, Mayo Clinic, GI Dynamics, More 01/18/13 Boston
Aileron Secures Funding for First Stapled Peptide Clinical Trial 01/14/13 Boston
ArQule’s Lead Cancer Drug Fails Another Clinical Trial 01/11/13 Boston
Biogen ALS Failure Highlights Clinical Trial Frustrations 01/10/13 Boston
Biogen Idec’s ALS Drug Fails Phase III Trial 01/03/13 Boston
East Coast Life Sciences Roundup: Blend, Amicus, Vertex, & More 12/21/12 Boston
Amicus-GlaxoSmithkline Drug for Fabry Disease Fails Clinical Trial 12/20/12 New York
Avaxia Gets $6.4 Million More for Anti-TNF Oral Drug Trial 12/18/12 Boston
Aastrom Names New Interim CEO, Mayleben To Remain Active in Fundraising 12/14/12 Detroit
Sarepta Announces Price of $125 Million Stock Offering 12/14/12 Boston
East Coast Life Sciences Roundup: Zafgen, Moderna, Merck, More 12/07/12 Boston
Flexion Therapeutics Secures $20 Million to Fight Osteoarthritis 12/04/12 Boston
East Coast Life Sciences Roundup: Selecta, Rib-X, Cambridge, & More 11/30/12 Boston
East Coast Life Sciences Roundup: Bristol-Myers, Alnylam, Merck, & More 11/16/12 Boston
Omeros Passes 2nd Trial for Eye Drug, Preps for FDA Push 11/05/12 Seattle
FDA Staff Issues Positive Report for Aegerion’s Lomatapide 10/15/12 Boston
Qualcomm Foundation Awards Scripps Health $3.75M for Digital Health 10/03/12 San Diego
Page 1 of 9 next page »